Form 4: Charles River Labs Executive Stock Disposition

Joseph W. LaPlume, EVP of Corporate Strategy & Development at Charles River Laboratories, reported the disposition of 428 shares to cover tax obligations.

Summary

• Joseph W. LaPlume, EVP of Corporate Strategy & Development, disposed of 243 shares of common stock on 05/26/2026 at a price of $160.30.
• An additional 185 shares were disposed of on 05/27/2026 at a price of $156.73.
• The total number of shares disposed of was 428.
• Following these transactions, the reporting person maintains a beneficial ownership of 27,020 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax obligations rather than a discretionary sale of stock.

Positives

• The reporting person retains a significant equity stake of 27,020 shares, indicating continued alignment with shareholder interests.

Negatives

• The filing reflects a reduction in the executive's direct share ownership.

Risks

• None identified; this is a routine administrative transaction related to tax withholding.

Future Outlook

Not applicable as this is a retrospective disclosure of an insider transaction.

Industry Context

StockSavvy.ai notes that tax-related share withholding is a standard corporate practice for executives and does not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for executive equity management.
• The use of 'sell-to-cover' transactions is a common industry practice for managing tax liabilities associated with restricted stock unit vesting.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was for tax withholding purposes.

Key Dates

Keywords

Charles River Laboratories, CRL, Insider Trading, Form 4, Executive Compensation, Stock Disposition